Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Plasmodium falciparum | protein farnesyltransferase subunit beta | 0.0264 | 0.7363 | 0.5 |
Trichomonas vaginalis | rap1 and, putative | 0.027 | 0.7974 | 1 |
Trichomonas vaginalis | ral, putative | 0.027 | 0.7974 | 1 |
Trypanosoma cruzi | lanosterol synthase, putative | 0.0289 | 1 | 1 |
Toxoplasma gondii | prenyltransferase and squalene oxidase repeat-containing protein | 0.0264 | 0.7363 | 0.5 |
Entamoeba histolytica | Ras family GTPase | 0.027 | 0.7974 | 1 |
Entamoeba histolytica | ras-1, putative | 0.027 | 0.7974 | 1 |
Leishmania major | farnesyltransferase beta subunit | 0.0264 | 0.7363 | 1 |
Trichomonas vaginalis | ras-dva small GTPase, putative | 0.027 | 0.7974 | 1 |
Brugia malayi | Ras protein let-60 | 0.027 | 0.7974 | 1 |
Trichomonas vaginalis | GTP-binding protein rit, putative | 0.027 | 0.7974 | 1 |
Loa Loa (eye worm) | Ras protein let-60 | 0.027 | 0.7974 | 1 |
Brugia malayi | Ras-related protein R-Ras2 | 0.027 | 0.7974 | 1 |
Giardia lamblia | Prenyltransferase | 0.0264 | 0.7363 | 0.5 |
Trypanosoma brucei | lanosterol synthase | 0.0289 | 1 | 1 |
Entamoeba histolytica | Ras family GTPase | 0.027 | 0.7974 | 1 |
Echinococcus multilocularis | ras gtpase | 0.027 | 0.7974 | 1 |
Trichomonas vaginalis | rheb, putative | 0.027 | 0.7974 | 1 |
Echinococcus granulosus | ras gtpase | 0.027 | 0.7974 | 1 |
Trypanosoma cruzi | lanosterol synthase, putative | 0.0289 | 1 | 1 |
Schistosoma mansoni | protein farnesyltransferase subunit beta | 0.0264 | 0.7363 | 0.5 |
Trichomonas vaginalis | dexras1, putative | 0.027 | 0.7974 | 1 |
Plasmodium vivax | farnesyltransferase beta subunit, putative | 0.0264 | 0.7363 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.027 | 0.7974 | 1 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.